Back to search

Article

Lineage-specific neutralising antibodies after SARS-CoV-2 mild disease. Immune boosting effect of vaccination

2024-11-08

Abstract excerpt

We followed a group of 105 non-vaccinated individuals after Alpha or Delta SARS-CoV-2 mild disease, measuring the viral shedding (qRT-PCR, dPCR and subgenomic RNA-E) and humoral response (commercial immunoassay and pseudovirus and live virus neutralisation) up to six months. Sixty nine patients received a vaccination boost during the follow-up period (n=95). Subgenomic RNA-E showed a shorter period until negativit...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
26936824-6fc7-5ed0-bd03-247411210fe2
DOI
10.1101/2024.11.08.622599
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Lineage-specific neutralising antibodies after SARS-CoV-2 mild disease. Immune boosting effect of vaccinationDOI 10.1101/2024.11.08.622599
Neutralising reactivity against SARS-CoV-2 Delta and Omicron variants by vaccination and infection historySemantic proximity
SARS-CoV-2 evolution and patient immunological history shape the breadth and potency of antibody-mediated immunitySemantic proximity
SARS-CoV2 wild type and mutant specific humoral and T cell immunity is superior after vaccination than after natural infectionSemantic proximity
SARS-CoV-2 infection in fully vaccinated individuals of old age strongly boosters the humoral immune responseSemantic proximity
Antibody response to SARS-CoV-2 infection in humans: a systematic reviewSemantic proximity
Neutralisation hierarchy of SARS-CoV-2 Variants of Concern using standardised, quantitative neutralisation assays reveals a correlation with disease severity; towards deciphering protective antibody thresholdsSemantic proximity
Neutralising antibodies predict protection from severe COVID-19Semantic proximity
The Persistence of Neutralising Antibodies up to 11 months after SARS-CoV-2 Infection in the Southern Region of New ZealandSemantic proximity
The Impact of SARS-CoV-2 Vaccination and Infection on Neutralising Antibodies: A Nation-Wide Cross-Sectional AnalysisSemantic proximity
Four doses of the inactivated SARS-CoV-2 vaccine redistribute humoral immune responses away from the Receptor Binding DomainSemantic proximity
Characterising heterogeneity and sero-reversion in antibody responses to mild SARS⍰CoV-2 infection: a cohort study using time series analysis and mechanistic modellingSemantic proximity
Sub-optimal Neutralisation of Omicron (B.1.1.529) Variant by Antibodies induced by Vaccine alone or SARS-CoV-2 Infection plus Vaccine (Hybrid Immunity) post 6-monthsSemantic proximity
Select a neighboring publication to make it the new centre.